<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
	<front>
		<journal-meta>
			<journal-title-group>
				<journal-title>Zaporozhye Medical Journal</journal-title>
			</journal-title-group>
			<issn pub-type="epub">2310-1210</issn>
			<issn pub-type="ppub">2306-4145</issn>
			<publisher>
				<publisher-name>Zaporizhzhia State Medical and Pharmaceutical University</publisher-name>
			</publisher>
		</journal-meta>
		<article-meta>
			<article-id pub-id-type="doi">10.14739/2310-1210.2025.2.320492</article-id>
			<title-group>
				<article-title>Predictors of the no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction due to stenotic coronary artery disease</article-title>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author">
					<name>
						<surname>Khaniukov</surname>
						<given-names>O. O.</given-names>
					</name>
					<xref ref-type="aff" rid="aff1"/>
					<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4146-0110</contrib-id>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Sapozhnychenko</surname>
						<given-names>L. V.</given-names>
					</name>
					<xref ref-type="aff" rid="aff1"/>
					<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6472-2235</contrib-id>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Smolianova</surname>
						<given-names>O. V.</given-names>
					</name>
					<xref ref-type="aff" rid="aff1"/>
					<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8654-381X</contrib-id>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Bashmakov</surname>
						<given-names>I. D.</given-names>
					</name>
					<xref ref-type="aff" rid="aff1"/>
					<contrib-id contrib-id-type="orcid">https://orcid.org/0009-0004-2697-7263</contrib-id>
				</contrib>
			</contrib-group>
			<aff id="aff1">Dnipro State Medical University</aff>
			<author-notes>
				<fn><p>Oleksandra Smolianova <email>405_19@dmu.edu.ua</email></p></fn>
			</author-notes>
			<pub-date pub-type="epub">
				<day>29</day>
				<month>04</month>
				<year>2025</year>
			</pub-date>
			<volume>27</volume>
			<issue>2</issue>
			<fpage>105</fpage>
			<lpage>109</lpage>
			<abstract>
				<p>Aim. To identify modifiable and non-modifiable risk factors for no-reflow syndrome in ST-segment elevation myocardial infarction (STEMI) patients undergoing reperfusion by balloon angioplasty.</p>
				<p>Materials and methods. We analyzed 392 patients with STEMI who underwent percutaneous coronary intervention (PCI). The patients were divided into 2 groups based on the presence of no-reflow syndrome. Clinical data, laboratory results and instrumental findings were compared between the groups.</p>
				<p>Results. A higher proportion of women has been observed among no-reflow patients compared to normal-flow group (33 % versus 22 %, p &lt; 0.05). A lower hemoglobin level has been found in the study group as compared to that in the control group: 132 g/L and 136 g/L, respectively (p &lt; 0.05). However, the same proportion of individuals with anemia has been documented in both groups (p = 0.79). Patients with no-reflow syndrome had lower glomerular filtration rate (GFR) compared to those in the normal-flow group – 61.1 mL/min/1.73 m2 versus 67.9 mL/min/1.73 m2 (p &lt; 0.05). Additionally, GFR &lt;60 mL/min/1.73 m2 has been more common in the study group (48 %) than in the control group (35 %). Lesion types of an infarct-related artery in patients with no-reflow have been presented significantly more often as acute occlusion (78 % versus 65 %, p &lt; 0.05) or thrombotic occlusion / subocclusion (6 % versus 1 %, p &lt; 0.05). In the cases of impeded distal blood circulation during PCI, thrombus extraction was performed in 9 % of patients, compared to only 2 % in the normal blood flow group (p &lt; 0.05). Female sex (OR 1.71 95 % CI 1.01–2.87), thrombus extraction (OR 4.24 95 % CI 1.49–12.05) and a patient belonging to the GFR &lt;60 mL/min/1.73 m2 category (OR 1.66 95 % CI 1.03–2.69) have been identified as the risk factors increasing the chances for developing no-reflow.</p>
				<p>Conclusions. Female sex represents a non-modifiable risk factor for the development of no-reflow phenomenon. GFR &lt;60 mL/min/1.73 m2 is a significant modifiable risk factor. Characteristics of the infarct-related artery lesion, such as acute occlusion or thrombotic occlusion / subocclusion, are associated with an increased risk of no-reflow.</p>
			</abstract>
			<kwd-group kwd-group-type="author">
				<kwd>acute myocardial infarction</kwd>
				<kwd>STEMI</kwd>
				<kwd>percutaneous coronary intervention</kwd>
				<kwd>no-reflow phenomenon</kwd>
				<kwd>risk factors</kwd>
			</kwd-group>
			<self-uri content_type="abstract">https://zmj.zsmu.edu.ua/article/view/320492</self-uri>
			<self-uri content_type="pdf">https://zmj.zsmu.edu.ua/article/download/320492/318140</self-uri>
		</article-meta>
	</front>
</article>
